118 related articles for article (PubMed ID: 9763842)
21. The burden of prenatal exposure to alcohol: revised measurement of cost.
Stade B; Ali A; Bennett D; Campbell D; Johnston M; Lens C; Tran S; Koren G
Can J Clin Pharmacol; 2009; 16(1):e91-102. PubMed ID: 19168935
[TBL] [Abstract][Full Text] [Related]
22. Costs and quality of life in multiple sclerosis in The Netherlands.
Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
[TBL] [Abstract][Full Text] [Related]
23. [Disease burden of nervous system disorders in The Netherlands].
van den Bosch JH; Kardaun JW
Ned Tijdschr Geneeskd; 1994 Jun; 138(24):1219-24. PubMed ID: 8015618
[TBL] [Abstract][Full Text] [Related]
24. [Estimated health care expenditures for 'demented' patients].
Ringoir DJ; van Duuren R
Gerontologie; 1981 Feb; 12(1):28-37. PubMed ID: 6783484
[TBL] [Abstract][Full Text] [Related]
25. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
[TBL] [Abstract][Full Text] [Related]
26. A national study of medical care expenditures for musculoskeletal conditions: the impact of health insurance and managed care.
Yelin E; Herrndorf A; Trupin L; Sonneborn D
Arthritis Rheum; 2001 May; 44(5):1160-9. PubMed ID: 11352250
[TBL] [Abstract][Full Text] [Related]
27. Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens JL; van der Heijde D; van der Linden S
Ann Rheum Dis; 2005 Mar; 64(3):396-402. PubMed ID: 15271773
[TBL] [Abstract][Full Text] [Related]
28. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
Zámbori J; Szádóczky E; Rózsa S; Füredi J
J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
[TBL] [Abstract][Full Text] [Related]
29. Determinants of costs of care for patients with Alzheimer's disease.
Jönsson L; Eriksdotter Jönhagen M; Kilander L; Soininen H; Hallikainen M; Waldemar G; Nygaard H; Andreasen N; Winblad B; Wimo A
Int J Geriatr Psychiatry; 2006 May; 21(5):449-59. PubMed ID: 16676288
[TBL] [Abstract][Full Text] [Related]
30. Demographic and epidemiological determinants of healthcare costs in Netherlands: cost of illness study.
Meerding WJ; Bonneux L; Polder JJ; Koopmanschap MA; van der Maas PJ
BMJ; 1998 Jul; 317(7151):111-5. PubMed ID: 9657785
[TBL] [Abstract][Full Text] [Related]
31. [Detailed analysis of the societal costs of diabetes mellitus].
van Os N; Niessen LW; Koopmanschap MA; van der Lei J
Ned Tijdschr Geneeskd; 2000 Apr; 144(18):842-6. PubMed ID: 10816774
[TBL] [Abstract][Full Text] [Related]
32. Costs of brain disorders in Finland.
Sillanpää M; Andlin-Sobocki P; Lönnqvist J
Acta Neurol Scand; 2008 Mar; 117(3):167-72. PubMed ID: 18081913
[TBL] [Abstract][Full Text] [Related]
33. Variation in use and costs of primary health and social services in mental health or drinking problems.
Forma L; Jarvala T; Ahonen J; Vitikainen K; Rissanen P
J Ment Health Policy Econ; 2009 Jun; 12(2):79-86. PubMed ID: 19567933
[TBL] [Abstract][Full Text] [Related]
34. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
Davis WA; Knuiman MW; Hendrie D; Davis TM
Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
[TBL] [Abstract][Full Text] [Related]
35. Relationship of fruit and vegetable consumption in middle-aged men to medicare expenditures in older age: the Chicago Western Electric Study.
Daviglus ML; Liu K; Pirzada A; Yan LL; Garside DB; Wang R; Van Horn L; Manning WG; Manheim LM; Dyer AR; Greenland P; Stamler J
J Am Diet Assoc; 2005 Nov; 105(11):1735-44. PubMed ID: 16256757
[TBL] [Abstract][Full Text] [Related]
36. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
[TBL] [Abstract][Full Text] [Related]
37. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
[TBL] [Abstract][Full Text] [Related]
38. A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan.
Croen LA; Najjar DV; Ray GT; Lotspeich L; Bernal P
Pediatrics; 2006 Oct; 118(4):e1203-11. PubMed ID: 17015508
[TBL] [Abstract][Full Text] [Related]
39. The economic costs of disease related malnutrition.
Freijer K; Tan SS; Koopmanschap MA; Meijers JM; Halfens RJ; Nuijten MJ
Clin Nutr; 2013 Feb; 32(1):136-41. PubMed ID: 22789931
[TBL] [Abstract][Full Text] [Related]
40. [Care of patients with dementia--a ticking cost bomb?].
Wimo A; Karlsson G; Sandman PO; Winblad B
Nord Med; 1995; 110(4):123-6. PubMed ID: 7724356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
